Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients
A completed clinical trial evaluating whether the biomarker NGAL can predict renal impairment, further decompensation, and rehospitalization…
-
FDA approval · 2015-01-20FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA granted a supplemental approval for CAPTOPRIL (captopril) from Camber Pharmaceuticals, Inc., updating the labeling for an existing capto…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Wireless, Intermittent Monitoring of Right Heart Pressures in HF [NA]
This entry notes the completion status of a CardioMEMS trial assessing wireless, intermittent monitoring of right heart pressures in heart f…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure [Phase 2]
A Phase 2 clinical trial (PROCLAIM) evaluating AC2592 delivered by continuous subcutaneous infusion in subjects with advanced congestive hea…
-
CLINICAL_TRIALS research · 2015-01-16Clinical Trial Update: Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF) [Phase 2]
This update documents the RESPECT-HF Phase 2 trial evaluating renal denervation in heart failure with preserved ejection fraction, with the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone [Phase 1, Phase 2]
This study reports safety, pharmacokinetics, and haemodynamic effects of a slow-release oral milrinone formulation. It included healthy volu…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients by Physiological Diagnosis (PhD) Function [Phase 4]
A Phase 4 study evaluating clinical status monitoring in implantable cardioverter defibrillator patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care
The trial update reports that the RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care trial sponsored by Response Biomedical Corp. has…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Trial update for a terminated prospective evaluation of heart failure patients with central sleep apnea.
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an Abbreviated New Drug Application for valsartan by Mylan Pharmaceuticals, enabling a generic version of the drug.
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for valsartan, a generic ARB. The product is indicated for hypertension, heart fai…
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for valsartan, a generic ARB, for hypertension, heart failure, and reducing cardiov…
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Aurobindo Pharma Limited)
FDA approves the Original Application for VALSARTAN from Aurobindo Pharma Limited, enabling the generic valsartan product to enter the marke…
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved Jubilant Cadista Pharmacuticals Inc.'s original ANDA for valsartan, a generic angiotensin II receptor blocker. The approval ena…
-
CLINICAL_TRIALS research · 2014-12-31Clinical Trial Update: Renal Denervation in Patients With Chronic Heart Failure and Resynchronization Therapy [Phase 2]
Phase 2 clinical trial update evaluating renal denervation in patients with chronic heart failure who have resynchronization therapy; curren…
-
FDA approval · 2014-12-24FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
FDA approved a supplemental application for Enalapril Maleate by Oceanside Pharmaceuticals under NDA 018998. The approval updates the produc…
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Exercise for Patients With Heart Failure in Primary Care: the EFICAR [Phase 3]
A Phase 3 clinical trial (EFICAR) is evaluating the impact of an exercise program for patients with heart failure in primary care; the curre…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function [Phase 4]
Phase 4 trial evaluating home monitoring for patients with heart failure and impaired left ventricular function; the study has completed.
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Advance Care Planning: A Way to Improve End-of-life Care Life Care [NA]
Update on a University of Aarhus study evaluating advance care planning to improve end-of-life care across heart failure, pulmonary disease,…
-
FDA approval · 2014-12-19FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC under the ANDA. The action approves changes to the al…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Prospective Observation of Exercise Parameters in Advanced Heart Failure
Completed results of a prospective observational study evaluating exercise parameters in patients with heart failure.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Neuron Specific Enolase in Ventricular Assist Device Recipients
Completed clinical trial studying neuron-specific enolase in recipients of left ventricular assist devices for advanced heart failure.
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Effect of High-flow Nasal Oxygen on Extubation Outcome [NA]
Clinical trial update examining whether high-flow nasal oxygen influences extubation outcomes in patients with respiratory failure, congesti…
-
FDA approval · 2014-12-11FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for lisinopril filed by Solco Healthcare U.S., LLC.
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Hemodynamic Effects of Spironolactone in Patients With Heart Failure [NA]
This update notes the completion of a clinical trial evaluating the hemodynamic effects of spironolactone in patients with heart failure.